The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges

The phosphatidylinositol 3 kinase (PI3K) pathway is frequently altered in cancer, including ovarian cancer (OC). Unfortunately, despite a sound biological rationale and encouraging activity in preclinical models, trials of first-generation inhibitors of mammalian target of rapamycin (mTOR) in OC hav...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chin J Cancer
Asıl Yazarlar: Cheaib, Bianca, Auguste, Aurélie, Leary, Alexandra
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Sun Yat-sen University Cancer Center 2015
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4302085/
https://ncbi.nlm.nih.gov/pubmed/25556614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.014.10289
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller